IL163593D0 - Preparation of paroxetine involving novel intermediates - Google Patents

Preparation of paroxetine involving novel intermediates

Info

Publication number
IL163593D0
IL163593D0 IL16359302A IL16359302A IL163593D0 IL 163593 D0 IL163593 D0 IL 163593D0 IL 16359302 A IL16359302 A IL 16359302A IL 16359302 A IL16359302 A IL 16359302A IL 163593 D0 IL163593 D0 IL 163593D0
Authority
IL
Israel
Prior art keywords
paroxetine
preparation
novel intermediates
involving novel
involving
Prior art date
Application number
IL16359302A
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US35891602P priority Critical
Application filed by Teva Pharma filed Critical Teva Pharma
Priority to PCT/US2002/013826 priority patent/WO2003072104A1/en
Publication of IL163593D0 publication Critical patent/IL163593D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
IL16359302A 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates IL163593D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US35891602P true 2002-02-22 2002-02-22
PCT/US2002/013826 WO2003072104A1 (en) 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates

Publications (1)

Publication Number Publication Date
IL163593D0 true IL163593D0 (en) 2005-12-18

Family

ID=27766019

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16359302A IL163593D0 (en) 2002-02-22 2002-05-01 Preparation of paroxetine involving novel intermediates
IL15823803A IL158238D0 (en) 2002-02-22 2003-02-24 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL15823803A IL158238D0 (en) 2002-02-22 2003-02-24 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide

Country Status (15)

Country Link
US (1) US6936720B2 (en)
EP (2) EP1482939A4 (en)
JP (2) JP2005524656A (en)
KR (1) KR20040099279A (en)
CN (1) CN1636002A (en)
AU (2) AU2002259114A1 (en)
CA (2) CA2476723A1 (en)
HR (1) HRP20040766A2 (en)
IL (2) IL163593D0 (en)
IS (1) IS7406A (en)
MX (1) MXPA04008109A (en)
NO (1) NO20043972L (en)
PL (1) PL372288A1 (en)
WO (2) WO2003072104A1 (en)
ZA (1) ZA200407018B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7291742B2 (en) 2003-01-10 2007-11-06 Dipharma S.P.A. Process for the preparation of benzo [d] isoxazol-3-yl-methanesulfonic acid and the intermediates thereof
SI1583748T1 (en) 2003-01-13 2010-03-31 Dainippon Sumitomo Pharma Co Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide
US7081539B2 (en) * 2004-03-25 2006-07-25 Dainippon Sumitomo Pharma Co., Ltd. One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
US20060084814A1 (en) * 2004-05-20 2006-04-20 Siva Kumar Bobba V Process for the preparation of zonisamide
US7745471B2 (en) 2004-06-18 2010-06-29 Chemagis Ltd. Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide
EP1964577B1 (en) 2005-05-05 2016-04-13 GlaxoSmithKline Intellectual Property Development Limited Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
WO2007016208A2 (en) * 2005-07-28 2007-02-08 Teva Pharmaceutical Industries Ltd. 1,2-benzisoxazole-3-methane-sulfonic acid ammonium salt
WO2007016209A2 (en) * 2005-07-28 2007-02-08 Teva Pharmaceutical Industries Ltd. Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process
US7268234B2 (en) * 2005-09-16 2007-09-11 Dainippon Sumitomo Pharma Co., Ltd. Method for sulfonation of 1,2-benzisoxazole-3-acetic acid
US7375233B2 (en) 2005-12-16 2008-05-20 Apotex Pharmachem Inc. Process for the preparation of zonisamide and the intermediates thereof
JP2010260826A (en) * 2009-05-08 2010-11-18 Sumitomo Chemical Co Ltd Method of manufacturing paroxetine hydrochloride semihydrate
CN102329278A (en) * 2010-07-13 2012-01-25 深圳市资福药业有限公司 Zonisamide crystal, preparation method thereof and medicinal composition containing zonisamide crystal
KR20180059606A (en) * 2016-11-25 2018-06-05 삼성디스플레이 주식회사 mask for deposition, manufacturing method thereof and manufacturing method of display apparatus
CN106810507B (en) * 2017-01-23 2019-06-21 珠海市海瑞德生物科技有限公司 A kind of environmentally protective synthetic method of Zonisamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033114B2 (en) 1976-12-16 1985-08-01 Dainippon Pharmaceutical Co
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
US5128354A (en) * 1987-12-29 1992-07-07 Dainippon Pharmaceutical Co., Ltd. Agent for treating ischemic brain damage
SK283608B6 (en) * 1995-02-06 2003-10-07 Smithkline Beecham Plc New forms of parotexin hydrochloride
JP3882224B2 (en) * 1996-05-31 2007-02-14 旭硝子株式会社 Method for producing paroxetine
GB9726907D0 (en) * 1997-12-19 1998-02-18 Smithkline Beecham Plc Novel compounds
GB9914583D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel process
JP2001139572A (en) * 1999-11-17 2001-05-22 Sumika Fine Chemicals Co Ltd Method for producing anhydrous paroxetinic hydrochloride 2-propanol solvate
PL373723A1 (en) * 2001-03-02 2005-09-05 Teva Pharmaceutical Industries Ltd. Process for the preparation of 1,2-benzisoxazole-3-acetic acid
WO2003020708A1 (en) * 2001-08-30 2003-03-13 Teva Pharmaceutical Industries Ltd. Zonisamide intermediate and synthesis

Also Published As

Publication number Publication date
CA2476723A1 (en) 2003-09-04
EP1482939A4 (en) 2005-10-12
US6936720B2 (en) 2005-08-30
CN1636002A (en) 2005-07-06
CA2475598A1 (en) 2003-09-04
PL372288A1 (en) 2005-07-11
JP2005524656A (en) 2005-08-18
AU2002259114A1 (en) 2003-09-09
US20040014983A1 (en) 2004-01-22
ZA200407018B (en) 2006-06-28
EP1472236A4 (en) 2006-04-19
WO2003072552A8 (en) 2004-09-23
EP1472236A1 (en) 2004-11-03
EP1482939A1 (en) 2004-12-08
AU2003219889A1 (en) 2003-09-09
MXPA04008109A (en) 2004-11-26
NO20043972L (en) 2004-09-22
KR20040099279A (en) 2004-11-26
IS7406A (en) 2004-08-17
IL158238D0 (en) 2004-05-12
WO2003072104A1 (en) 2003-09-04
WO2003072552A1 (en) 2003-09-04
HRP20040766A2 (en) 2005-02-28
JP2005526049A (en) 2005-09-02

Similar Documents

Publication Publication Date Title
HUS1600042I1 (en) Therapeutic use of anti-CS1 antibodies
DE60312701D1 (en) Preparation of 1H-imidazo-4,5-quinoline-4-amines via novel 1H-imidazo-4,5-quinoline-4-cyano and 1H-imidazo-4,5-quinoline-4-carboxamidointermediates
TWI318201B (en) Novel succinate salt of o-desmethyl-venlafaxine
GB2432159B (en) Intermediates for manufacturing peripherally-selective inhibitors of dopamine-beta-hydroxylase
PL216662B1 (en) Vaccine composition
PT2258711T (en) New forms of 5-azacytidine
DE60333230D1 (en) Transparenter edge of network-datencache
DK1373230T3 (en) Enantiselective synthesis of azetidinone intermediates
GB0325192D0 (en) Method of use
HK1079461A1 (en) Analgesic uses of (s)-norketamine
AU154703S (en) Set of trocars
HK1069285A1 (en) Improved synthesis of polyanhyrides
HK1080372A1 (en) Novel tissue factor targeted antibodies as anticoagulants
DE60334973D1 (en) Aerosol formulations of diisobutyryl apomorphine
HK1079766B (en) METHOD OF SYNTHESIZING 1α-HYDROXY-2-METHYLENE-19-NOR-HOMOPREGNACALCIFEROL
AU2003217105A1 (en) Novel of cytokine inhibitors
AU2003236991A8 (en) Representations of processes
AP1955A (en) Novel crystalline modification of the anhydrate ofboscalid
HK1082497A1 (en) Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
HU0304041A3 (en) Compounds useful as intermediates
GB0220158D0 (en) Method of scanning
AT359077T (en) Oral given of 6-hydroxy-oxymorphone as analgetic
PL374874A1 (en) Use of erythropoietin
EP1745573A4 (en) Methods of manufacture of 2 -deoxy- beta-l-nucleosides
HK1093483A1 (en) Polymorphic form of n-